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Background: Substance use during pregnancy can have numerous detrimental effects on 
maternal and infant health. This knowledge contributes to high rates of abstinence during 
pregnancy, but pregnant women with substance use disorders are at high risk for relapse 
postpartum. Experiences of violence can have a substantial impact on the behavioral and 
mental health of women; its compounded consequences with those of substance use can lead 
to a population vulnerable to drug relapse and other negative health effects. The objective of 
this study was to examine the association between experiences of violence and drug abstinence 
at delivery and postpartum. 
Methods:  Data were collected as part of a longitudinal randomized control trial observing the 
effects of cognitive behavioral therapy on maternal outcomes among pregnant women with 
substance use disorder. Pregnant women (n=152) were recruited from Yale New Haven 
Hospital and Bridgeport hospital between 2006 and 2012 and completed surveys at intake and 
3 months postpartum. Logistic regression was used to examine associations between 
experiences of violence, sociodemographic characteristics, and rates of abstinence at delivery 
and at 3 months postpartum.  
Results: Of the 152 total participants, approximately 84% achieved abstinence at delivery and 
24% achieved abstinence at 3 months postpartum. Black participants had significantly lower 
odds than white participants of achieving abstinence at delivery (OR: 0.33, CI: 0.09, 1.21) and 3 
months postpartum (OR: 0.34, CI: 0.09, 1.27). Having ever experienced violence was not 
associated with drug abstinence at either time point assessed. 
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Conclusion: Drug abstinence during pregnancy and postpartum is a crucial indicator of 
maternal, fetal, and infant health. Further research is warranted to identify key factors that can 
contribute to prolonged drug abstinence among pregnant women and new mothers in order to 
tailor effective intervention efforts toward continuous abstinence for this population. 
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Substance use disorder is an increasing public health concern in the United States (Schulden et 
al., 2009). In 2012, approximately 22.2 million individuals in the United States – approximately 
7% of the population - were identified as having a substance dependence or substance use 
disorder (Substance Abuse and Mental Health Services Administration, 2013). Though men 
have previously been shown to have higher rates of substance use, the gap in rates of 
substance use disorder between genders has declined (Greenfield et al., 2010, Abuse, 2018). 
There are numerous gender and sex differences in the factors that lead to the initiation and 
maintenance of illicit substance use in the United States (Brady & Randall, 1999, Greenfield et 
al., 2010). Differences in use between genders is associated with biological differences in 
addiction mechanisms and tolerance, as well as social and gender roles for men and women 
(National Institute on Drug Abuse, 2018). Women may be more likely to experience craving, 
relapse, and addiction with smaller amounts of substance compared to men and are more likely 
to face societal scrutiny and judgment than men (Abuse, 2018, Brady Randall, 1999).  
 
As prevalence of substance use disorder among women has increased, rates of substance use 
during pregnancy and at delivery have likewise risen (National Institute on Drug Abuse, 2018). 
Estimates suggest that approximately 16% of pregnant women in 2012 reported smoking 
cigarettes in the past month, while about 6% of pregnant women reported using illicit 
substances in the past month (Substance Abuse and Mental Health Services Administration, 
2013). Substance use disorder during pregnancy can lead to multiple negative outcomes 
including lack of prenatal care engagement, infant withdrawal and resulting complications, and 
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higher rates of infectious disease (Wong et al., 2011). Drug abstinence tends to increase during 
pregnancy potentially as a result of knowledge, education, and social understanding of its 
detrimental effects, particularly on infant health (Bailey et al., 2008). However, likelihood of 
substance use relapse increases after delivery, an unfortunate phenomenon during a critical 
attachment time period for maternal child bonding and time of highest infant need and care 
but also of high maternal stress levels and need for family and healthcare support (Forray, 
2016, Suchman et al., 2005). Further research is warranted to better understand lifetime 
conditions and factors associated with maintaining abstinence postpartum. 
 
Violence against women is also known to be a substantial public health concern in the United 
States with over 30% of women reporting having experienced violence at some point in their 
lifetime (Breiding et al., 2010, Montgomery et al., 2015). Women who have experienced 
violence, in conjunction with those who have substance use disorders, comprise a critical group 
subject to the compounding and combined effects of violence and substance use especially in 
these circumstances’ associations with each other. For example, recent findings by Reed and 
colleagues (2015) highlight the lasting impact of experiences of violence on South African 
women’s drug use outcomes; rates of abstinence were significantly lower for participants who 
had experienced violence (Reed et al., 2015). There have been few studies on the impact of 
violence against women on rates of drug abstinence and relapse among pregnant women with 
substance use disorders to corroborate or challenge these findings. Additionally, previous 
research on risk factors associated with relapse among pregnant and postpartum women is 
primarily limited to single rather than multiple substance use, which limits the generalizability 
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and applicability of results to a broader substance-using population as it is relatively uncommon 
for someone to just use one substance.  
 
This study’s objective is to examine the association between experiences of violence and drug 
abstinence at delivery and postpartum among pregnant women with substance use disorders. 
Developing a better understanding of factors associated with achieving and maintaining 
abstinence during and after pregnancy can be highly beneficial in creating interventions to 






This study is a secondary analysis of data collected as part of a large-scale and multicenter 
randomized control trial assessing the effectiveness of a motivational enhancement and 
cognitive skills training therapy combined behavioral treatment. Participants in this 
Psychosocial Research to Improve Drug Treatment in Pregnancy (PRIDE-P) were assigned to 
motivational enhancement therapy (MET) with cognitive behavioral therapy (CBT) or brief 
advice (BA) delivered by a specialized provider. The outcome of interest for the PRIDE-P study 
was a decrease in use of psychoactive substances among pregnant women who were substance 
dependent or using.  
 
Between 2006 and 2012, participants were recruited at Yale New Haven Hospital (YNHH) 
Women’s Center in New Haven, CT and Bridgeport Hospital Ob/Gyn Primary Care Clinic in 
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Bridgeport, CT, and were eligible if they were age 16 or older, currently pregnant, and active 
users of one or more substances during pregnancy as determined at intake by the Addiction 
Severity index and medical testing (Yonkers et al., 2012).  Participants must have been able to 
speak English or Spanish to communicate with clinicians, accessible for follow-up (i.e. provide 3 
familial contacts, not have pending legal cases that may lead to incarceration), able to give 
informed consent, and eligible for outpatient treatment. Participants must not have been 
currently engaged with any form of substance use treatment, including medication assisted 
treatment or psychological treatment. Patients (n=2661) at these healthcare centers were 
assessed for eligibility by inclusion criteria. One hundred and fifty-two participants total were 
assessed, consented, and enrolled as the experimental cohort, and 127 participants achieved 













Figure 1 Study cohort flow and development (Forray et al., 2015) 
 
All participants completed a survey interview administered by a trained research assistant (RA) 
upon intake to the study, at 3 months postpartum, at 12 months postpartum, and at 24 months 
postpartum. Each questionnaire is a compilation of screening scales covering a variety of topics, 
such as demographic information, Addiction Severity Index, Structured Clinical Interview for 
DSM-IV, HIV Risk Behavior Scale, The Inventory of Depressive Symptomology, and other 
independent questions regarding family dynamics and relationships, pregnancy complications, 
and other specific information (McLellan et al., 1992, First et al., 2007, Ward et al., 1990, Rush 
et al., 1986, 1996). A breath test for alcohol was administered and a urine sample was collected 
when possible contingent on catheter placement in each participant; catheter placement 
 




prevented urine sample collection. Participants were offered unlimited therapy sessions 
through pregnancy and 2 sessions postpartum following assessment and participation in the 
study. Sessions were randomly selected and reviewed for agreement with Yale Adherence and 
Competence System (Carroll et al., 2000). The analyses for this study use data collected at 
intake and 3-months postpartum. 
 
Measures  
Primary outcome: Complete abstinence at 3-months postpartum 
Abstinence was defined as complete abstinence from all substances at the 3-month follow-up 
time point, as measured by self-report and medical screening. For this study, a lack of 
abstinence was characterized as relapse; through actively identifying the outcome of interest as 
abstinence, we simultaneously assessed relapse rates at delivery and 3-months postpartum. 
 
Primary predictors: Violence  
Participants’ experiences of violence were assessed through questionnaire items asking if they 
had ever been raped, molested, physically assaulted, hit, kicked, slapped, or threatened at any 
point in the past separately. If a participant reported ever experiencing any of these acts of 
violence, they were characterized as a victim of violence. 
 
Control variables 
Analyses controlled for sociodemographic factors and health behaviors linked to substance use 
relapse or experiences of violence in previous research. Covariates included maternal age (<20, 
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20-34, >=35), race/ethnicity (White, Black, Hispanic/Other), education (less than high school, 
high school, more than high school), and relationship status (married/living with partner, not 
married or cohabitating). Analyses also controlled for study condition assignment of CBT or BA. 
 
Statistical Analysis 
Descriptive characteristics of the participants overall and those who were abstinent at delivery 
were analyzed using chi square tests. Bivariate logistic regression models were used to analyze 
the association between sociodemographic characteristics, any experiences of violence in the 
past, and drug abstinence at delivery and 3-months postpartum. Variables associated with 
abstinence at less than 0.10 significance level were analyzed in a multivariable logistic 
regression model for each time point. All data analyses and dataset construction were 




Table 1 provides descriptive information regarding the sample overall as well as by experience 
of violence. Approximately half of sample is between the age of 20 and 34 (52.4%), with about 
30% being below 20 years old and about 20% being 35 years old or higher. The majority 
identified as black (55.0%), 22% as White, and 26% as Hispanic or other race/ethnicity. 
Approximately one-third of participants had less than a high school level of education (33.6%), 
38% had a high school degree or equivalent, and 29% had more than a 12th grade education. 
Thirty-five percent the sample were married or cohabitating with a spouse or partner. At 
intake, 29% of women used cigarettes, 23% used alcohol, 35% used marijuana, and 30% used 
cocaine. Approximately 65% of participants reported having ever experienced violence. There 
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were no significant differences in the sociodemographic characteristics of women who had 
experience violence versus those who had not. 
 
Table 1 Sample characteristics, n (%) 





Did not Experience 
Violence (n=55) 
Age    
   <20 42 (28.2) 24 (25.5) 18 (32.7) 
   20-34 78 (52.4) 49 (52.13) 29 (52.7) 
   35≤ 29 (19.5) 21 (22.3) 8 (14.6) 
Race    
   White 33 (22.2) 23 (24.5) 10 (18.2) 
   Black 82 (55.0) 51 (54.3) 31 (56.4) 
   Hispanic/other 34 (22.8) 20 (21.3) 14 (25.5) 
Education    
   Less Than High School 50 (33.6) 33 (35.1) 17 (30.9) 
   High School 56 (37.6) 29 (30.9) 27 (49.1) 
   More Than High School 43 (28.9) 32 (34.0) 11 (20.0) 
Marital Status    
   Married/Living with Partner 53 (35.1) 30 (31.9) 23 (40.4) 
   Not Married or Cohabitating 98 (64.9) 64 (68.1) 34 (59.7) 
Substance Use at Intakeb    
   Cigarettes 83 (28.7) 54 (28.0) 29 (30.2) 
   Alcohol 75 (23.0) 49 (25.4) 26 (27.1) 
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   Marijuana 101 (35.0) 67 (34.7) 34 (35.4) 
   Cocaine 30 (10.4) 32 (11.9) 7 (7.3) 
Treatment Group    
   BA 76 (51.0) 47 (50.0) 29 (52.7) 
   CBT 73 (49.0) 47 (50.0) 26 (47.3) 
Abstinent at delivery    
   Yes 126 (83.4) 82 (87.2) 44 (77.2) 
   No 25 (16.6) 12 (12.8) 13 (22.8) 
Abstinent 3 months postpartum    
   Yes 35 (24.1) 19 (21.4) 16 (28.6) 
   No 110 (75.9) 70 (78.7) 40 (71.4) 
aNumbers may not sum to total due to missing data 
bWomen may be using multiple substances, numbers may add up to more than total 
 
Of the 152 participants enrolled in the study cohort, 127 (83.6%) achieved abstinence at 
delivery, and 36 (23.7%) achieved abstinence through 3 months postpartum. Table 2 shows the 
logistic regression results. Compared to White participants, Black women had significantly 
lower odds of being abstinent at delivery (OR: 0.33, CI:0.09, 1.21). No other characteristics 
assessed were associated with abstinence at delivery. In bivariate analyses, Hispanic/other 
participants had a significantly greater likelihood of being abstinent at 3 months postpartum 
than those who were White (OR: 3.19, CI:1.04, 9.83), while being married or living with a 
partner was associated with decreased odds of being abstinent at 3 months postpartum 
compared to not being married or cohabitating at a 0.05 significant level (OR: 0.39, CI:0.16, 
0.97). At a 0.10 significance level, women who had higher than a high school degree had a 
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lower likelihood than those who had high school or lower to achieve abstinence at 3 months 
postpartum and women in the CBT treatment group of the PRIDE-P study were more likely than 
those assigned to the BA group to achieve abstinence at 3 months postpartum (OR: 0.34, 
CI:0.12, 0.98; OR: 2.00, CI:0.93, 4.31). In a multivariate model, only race remained 
independently associated with abstinence at 3-months postpartum; black women had 
decreased odds of achieving abstinence at 3-months postpartum compared to white women 
(OR: 0.34, CI: 0.09, 1.27). 
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Table 2 Associations of violence and variables with abstinence at delivery and at 3 months postpartum 
 Achieved Abstinence at delivery (n=127) Achieved Abstinence at 3 months postpartum 
(n=36) 
 OR (95% CI) OR (95% CI) 
 Unadjusted Adjusted Unadjusted Adjusted 
Violence     
   Experienced Violence 2.02 
 (0.85, 4.80) 
-- 0.68  
(0.31, 1.47) 
-- 
   Did not Experience Violence 1.00 -- 1.00 -- 
Age     
   <20 1.00 -- 1.00 -- 










Race     
   White 1.00 -- 1.00 -- 






   Hispanic/other 1.65  
(0.26, 10.56) 
 3.19 




Education     
   Less Than High School 1.00 -- 1.00 -- 






   More Than High School 0.82  
(0.26, 2.55) 




Marital Status     






   Not Married or Cohabitating 1.00 -- 1.00 -- 
Treatment Group     
   BA 1.00 -- 1.00 -- 













This study illuminated rates of abstinence among pregnant women and new mothers who 
entered pregnancy with substance use disorders. A large portion of women achieved 
abstinence by delivery (84%). However only a small proportion (27%) were abstinent by 3 
months postpartum demonstrating the need for additional support to prevent relapse for new 
mothers. Factors associated with new, particularly first-time motherhood, such as extreme 
fatigue, constant demands of their infant, and loss of personal time and space, can contribute 
to stress and lower rates of abstinence following delivery (McVeigh 1997). This study’s findings 
suggest that black women are less likely to be abstinent at delivery and 3 months postpartum 
compared to white women. These rates may be a result of varying access to prenatal care as 
well as the contribution of community support postpartum by race in New Haven (Wright et al 
2012). 
 
This study has numerous limitations that may have affected the findings. Firstly, the 
measurement of experienced violence includes any single experience of violence at any point in 
the participants’ lives; the severity and timing of the experience could minimize its impact on 
drug abstinence and relapse rates later in life. Additionally, the grouping of different 
experiences of violence into one variable to describe these experiences, such as getting hit or 
slapped and being raped or molested, is problematic due to vast differences in the severity of 
violence and its longitudinal impact of physical and mental health. This study’s outcome of 
continued abstinence may be impacted by different combinations of substances used at a time; 
for example, women who used alcohol were more likely to achieve abstinence at delivery than 
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women who used cigarettes. Future studies should account for the type of substance use 
disorder women are experiencing at intake. Power to detect significant differences may have 
been limited by the study’s small sample size. Also, the sample of women in this cohort 
received clinical care in New Haven, CT and Bridgeport, CT; therefore, conclusions may not be 
generalizable to populations that vary in demographics, culture, and access to substance use 
treatment and other healthcare resources. Another limitation of this study is that this 
preliminary analysis did not include common psychosocial variables, such as depressive 
symptoms or post-traumatic stress disorder (PTSD), that are prevalent among pregnant women 
and may influence drug abstinence and relapse in this population. Future analyses should 
include a broader range of covariates associated with maternal substance use outcomes. Lastly, 
data were not available about patients who were eligible but excluded from the study due to 
missing data or for declining to participate. There may be systematic differences between them 
and those who were included that may contribute to higher risk of relapse and inability to 
achieve or maintain drug abstinence at delivery and at postpartum time points (Figure 1). 
 
Nonetheless, this study extends previous work done with these data and outcomes of drug 
abstinence and other factors of interest such as contraceptive use (Loree et al 2018). Further 
research into this topic is highly warranted in addition to replication studies with larger 
datasets. Future studies should identify and examine other factors that have a substantial 
impact on the rate of continuous drug abstinence to benefit maternal, fetal, and infant health 
outcomes. These studies can be used to adapt intervention efforts and clinical practice to 
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